NO984761L - Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler - Google Patents
Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midlerInfo
- Publication number
- NO984761L NO984761L NO984761A NO984761A NO984761L NO 984761 L NO984761 L NO 984761L NO 984761 A NO984761 A NO 984761A NO 984761 A NO984761 A NO 984761A NO 984761 L NO984761 L NO 984761L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- halogen
- alkoxy
- optionally substituted
- hydrogen
- Prior art date
Links
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- OSILBMSORKFRTB-UHFFFAOYSA-N isoquinolin-1-amine Chemical class C1=CC=C2C(N)=NC=CC2=C1 OSILBMSORKFRTB-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 229910052736 halogen Inorganic materials 0.000 abstract 6
- 150000002367 halogens Chemical class 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 3
- 125000005936 piperidyl group Chemical group 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000005605 benzo group Chemical group 0.000 abstract 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004001 thioalkyl group Chemical group 0.000 abstract 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9607717.7A GB9607717D0 (en) | 1996-04-13 | 1996-04-13 | Pharmaceutically active comounds |
| GBGB9608678.0A GB9608678D0 (en) | 1996-04-26 | 1996-04-26 | Pharmaceuticlly active compounds |
| GBGB9610892.3A GB9610892D0 (en) | 1996-05-24 | 1996-05-24 | Pharmaceutically active compounds |
| PCT/SE1997/000589 WO1997038977A1 (en) | 1996-04-13 | 1997-04-09 | Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO984761D0 NO984761D0 (no) | 1998-10-12 |
| NO984761L true NO984761L (no) | 1998-12-14 |
Family
ID=27268241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO984761A NO984761L (no) | 1996-04-13 | 1998-10-12 | Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6063789A (is) |
| EP (1) | EP0892784A1 (is) |
| JP (1) | JP2000509028A (is) |
| KR (1) | KR20000005388A (is) |
| CN (1) | CN1221407A (is) |
| AR (1) | AR006619A1 (is) |
| AU (1) | AU706110B2 (is) |
| BR (1) | BR9708607A (is) |
| CA (1) | CA2251681A1 (is) |
| CZ (1) | CZ327698A3 (is) |
| EE (1) | EE9800339A (is) |
| HU (1) | HUP9901739A3 (is) |
| ID (1) | ID16575A (is) |
| IL (1) | IL126476A0 (is) |
| IS (1) | IS4862A (is) |
| NO (1) | NO984761L (is) |
| NZ (1) | NZ331932A (is) |
| PL (1) | PL329308A1 (is) |
| SK (1) | SK134698A3 (is) |
| TR (1) | TR199802060T2 (is) |
| WO (1) | WO1997038977A1 (is) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69830410T2 (de) | 1997-08-29 | 2006-01-26 | Tularik Ltd. | Meta-benzamidinderivate als serinprotease-inhibitoren |
| WO1999011622A1 (en) * | 1997-09-03 | 1999-03-11 | Guilford Pharmaceuticals Inc. | Amino-substituted compounds, methods, and compositions for inhibiting parp activity |
| EP1100789B1 (de) | 1998-07-24 | 2005-02-09 | Bayer CropScience AG | Substituierte benzoylcyclohexandione |
| IT1302677B1 (it) | 1998-10-15 | 2000-09-29 | Zambon Spa | Derivati benzazinici inibitori della fosfodiesterasi 4 |
| TW575567B (en) * | 1998-10-23 | 2004-02-11 | Akzo Nobel Nv | Serine protease inhibitor |
| SE9901530D0 (sv) * | 1999-04-28 | 1999-04-28 | Astra Pharma Prod | Novel compounds |
| DE19920791A1 (de) | 1999-05-06 | 2000-11-09 | Bayer Ag | Substituierte Benzoylisoxazole |
| DE19921424A1 (de) | 1999-05-08 | 2000-11-09 | Bayer Ag | Substituierte Benzoylketone |
| DE19946853A1 (de) | 1999-09-30 | 2001-04-05 | Bayer Ag | Substituierte Arylketone |
| TW591031B (en) * | 2000-02-29 | 2004-06-11 | Takeda Chemical Industries Ltd | Thienopyridine derivatives, their production and use |
| US7012098B2 (en) * | 2001-03-23 | 2006-03-14 | Pharmacia Corporation | Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
| ES2572263T3 (es) | 2005-10-25 | 2016-05-31 | Shionogi & Co | Derivados de dihidrooxazina y tetrahidropirimidina como inhibidores de BACE 1 |
| TW200804290A (en) * | 2005-11-15 | 2008-01-16 | Astrazeneca Ab | Compounds and uses thereof |
| EP2151435A4 (en) | 2007-04-24 | 2011-09-14 | Shionogi & Co | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
| EP2147914B1 (en) | 2007-04-24 | 2014-06-04 | Shionogi&Co., Ltd. | Aminodihydrothiazine derivatives substituted with cyclic groups |
| KR101324426B1 (ko) | 2008-06-13 | 2013-10-31 | 시오노기세야쿠 가부시키가이샤 | β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체 |
| EP2360155A4 (en) | 2008-10-22 | 2012-06-20 | Shionogi & Co | 2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT |
| CN102834384A (zh) | 2009-12-11 | 2012-12-19 | 盐野义制药株式会社 | *嗪衍生物 |
| CN101863900B (zh) * | 2010-06-29 | 2012-07-25 | 天津药物研究院 | 一氧化氮供体型噻吩并吡啶衍生物、其制备方法和用途 |
| US9018219B2 (en) | 2010-10-29 | 2015-04-28 | Shionogi & Co., Ltd. | Fused aminodihydropyrimidine derivative |
| WO2012057248A1 (ja) | 2010-10-29 | 2012-05-03 | 塩野義製薬株式会社 | ナフチリジン誘導体 |
| EP2703399A4 (en) | 2011-04-26 | 2014-10-15 | Shionogi & Co | OXAZINE DERIVATIVE AND BACE-1 HEMMER THEREOF |
| WO2014065434A1 (en) | 2012-10-24 | 2014-05-01 | Shionogi & Co., Ltd. | Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3663550A (en) * | 1968-12-25 | 1972-05-16 | Shionogi & Co | 2-lower alkyl-2,3-dihydrothieno(3,2-c)quinoline oxides |
| US3903095A (en) * | 1972-02-18 | 1975-09-02 | Merck & Co Inc | Certain substituted-thieno{8 3,2-c{9 -pyridines |
| GB1379111A (en) * | 1972-04-13 | 1975-01-02 | Aspro Nicholas Ltd | Preparation of fused-ring pyridine and pyrazine derivatives |
| US4127720A (en) * | 1977-09-21 | 1978-11-28 | Bristol-Myers Company | Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity |
| JPH04348326A (ja) * | 1990-07-09 | 1992-12-03 | Sumitomo Electric Ind Ltd | 有機非線形光学材料 |
| CN1077886C (zh) * | 1993-10-21 | 2002-01-16 | G·D·瑟尔公司 | 用作一氧化一氮合酶抑制剂的脒基衍生物 |
-
1997
- 1997-04-09 JP JP9537011A patent/JP2000509028A/ja active Pending
- 1997-04-09 CN CN97195337A patent/CN1221407A/zh active Pending
- 1997-04-09 EP EP97918449A patent/EP0892784A1/en not_active Withdrawn
- 1997-04-09 HU HU9901739A patent/HUP9901739A3/hu unknown
- 1997-04-09 PL PL97329308A patent/PL329308A1/xx unknown
- 1997-04-09 US US08/894,448 patent/US6063789A/en not_active Expired - Fee Related
- 1997-04-09 NZ NZ331932A patent/NZ331932A/en unknown
- 1997-04-09 WO PCT/SE1997/000589 patent/WO1997038977A1/en not_active Application Discontinuation
- 1997-04-09 CA CA002251681A patent/CA2251681A1/en not_active Abandoned
- 1997-04-09 BR BR9708607A patent/BR9708607A/pt unknown
- 1997-04-09 EE EE9800339A patent/EE9800339A/xx unknown
- 1997-04-09 KR KR1019980708115A patent/KR20000005388A/ko not_active Application Discontinuation
- 1997-04-09 CZ CZ983276A patent/CZ327698A3/cs unknown
- 1997-04-09 TR TR1998/02060T patent/TR199802060T2/xx unknown
- 1997-04-09 SK SK1346-98A patent/SK134698A3/sk unknown
- 1997-04-09 AU AU26550/97A patent/AU706110B2/en not_active Ceased
- 1997-04-09 IL IL12647697A patent/IL126476A0/xx unknown
- 1997-04-11 AR ARP970101464A patent/AR006619A1/es not_active Application Discontinuation
- 1997-04-14 ID IDP971239A patent/ID16575A/id unknown
-
1998
- 1998-10-07 IS IS4862A patent/IS4862A/is unknown
- 1998-10-12 NO NO984761A patent/NO984761L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000509028A (ja) | 2000-07-18 |
| AU706110B2 (en) | 1999-06-10 |
| IS4862A (is) | 1998-10-07 |
| WO1997038977A1 (en) | 1997-10-23 |
| PL329308A1 (en) | 1999-03-15 |
| IL126476A0 (en) | 1999-08-17 |
| HUP9901739A2 (hu) | 1999-09-28 |
| NO984761D0 (no) | 1998-10-12 |
| SK134698A3 (en) | 1999-06-11 |
| AR006619A1 (es) | 1999-09-08 |
| EE9800339A (et) | 1999-04-15 |
| EP0892784A1 (en) | 1999-01-27 |
| ID16575A (id) | 1997-10-16 |
| BR9708607A (pt) | 1999-08-03 |
| TR199802060T2 (xx) | 1999-01-18 |
| AU2655097A (en) | 1997-11-07 |
| CA2251681A1 (en) | 1997-10-23 |
| CN1221407A (zh) | 1999-06-30 |
| US6063789A (en) | 2000-05-16 |
| CZ327698A3 (cs) | 1999-05-12 |
| HUP9901739A3 (en) | 2000-06-28 |
| KR20000005388A (ko) | 2000-01-25 |
| NZ331932A (en) | 2000-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO984761L (no) | Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler | |
| NO20064089L (no) | Kondensert ring 4-oksopyrimidinderivat | |
| NO20072116L (no) | Farmasoytiske forbindelser | |
| ATE353870T1 (de) | Dibenzylaminverbindung und deren medizinische verwendung | |
| NO20092770L (no) | Nye aminopyrimidinderivater som PLK1-inhibitorer | |
| NO20055316L (no) | Nye heterocykliske forbindelser som er nyttige ved behandling av inflammatoriske og allergiske forstyrrelser, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger som inneholder slike | |
| PL373888A1 (en) | 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides | |
| NO20053483L (no) | 4-Anilinokinazolinderivater for behandling av unormal cellevekst | |
| NO20052038L (no) | Ny adeninforbindelse og anvendelse derav | |
| NO20083114L (no) | Polysykliske indazolderivater som er ERK-inhibitorer | |
| NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
| KR950003275A (ko) | 1-벤젠술포닐-1, 3-디히드로-2h-벤즈이미다졸-2-온 유도체 | |
| NO20062370L (no) | Amidderivater | |
| NZ595829A (en) | 8-[4-(1-Aminocyclobutyl)phenyl]-9-phenyl[1,2,4]triazolo[3,4-f]-1,6-naphthyridine derivatives | |
| MY142807A (en) | Benzimidazole derivative and use thereof. | |
| EP1813270A4 (en) | PROTEIN INHIBITORS OF THE HSP90 FAMILY | |
| EP1679069A4 (en) | NEW PIPERIDINE DERIVATIVE | |
| NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| NO20072806L (no) | Aryloksy-substituerte benzimidazolderivater | |
| EA200601177A1 (ru) | Пиридо- и пиримидопиримидиновые производные в качестве антипролиферативных агентов | |
| FI942635A0 (fi) | Piperatsiinijohdannaiset 5HT1A-antagonisteina | |
| DE3868301D1 (de) | 2-(methyl(4-piperidinyl))-1,2,3,4-tetrahydro-9h-pyrido(3,4-b)indolderivate, ihre herstellung und therapeutische verwendung. | |
| NO20072643L (no) | Fenylpiperazinmethanonderivater | |
| NO20073283L (no) | Nye pyridotienopyrimidinderivater | |
| NO307087B1 (no) | 3-(hetero)arylkarboksylsyrederivater, midler inneholdende dem, anvendelse av dem og mellomprodukter i deres fremstilling |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |